[Prevention of hepatitis B virus infection]. 1990

Y Kosaka, and M Yamashiki
Department of Clinical laboratory Medicine, Mie University School of Medicine, Tsu.

The incidence of the carrier of hepatitis B virus (HBV) in Japan is about ten times higher than that in U.S.A. and Western Europe. Countermeasures against HBV infection have been proposed on a national basis. The main route of HBV infection is due to contamination of blood and secretion from the carrier of HBV. The contamination would occur in many circumstances such as in the case of blood transfusion, needle accidents in hospital, vertical infection from mother to baby at the time of delivery and infection within family members. To prevent the posttransfusion hepatitis due to HBV, rapid and high sensitive measurement of HBs antigen should be introduced. Countermeasures have begun against the vertical infection from mother to baby at the time of delivery by the National Treasury. Already, a good result has been obtained. Recently the vaccination against HBV is generally performed. However, a low incidence of people have a high anti-HBs titer for a long period. The new countermeasure against this problem should be worked up as soon as possible.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014761 Viral Hepatitis Vaccines Any vaccine raised against any virus or viral derivative that causes hepatitis. Hepatitis, Viral, Vaccines,Hepatitis Vaccines, Viral,Vaccines, Viral Hepatitis
D065227 Transfusion Reaction Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility. Delayed Hemolytic Transfusion Reaction,Acute Hemolytic Transfusion Reaction,Blood Transfusion-Associated Adverse Reactions,Delayed Serologic Transfusion Reaction,Febrile Non-Hemolytic Transfusion Reaction,Hemolytic Transfusion Reaction,Hypotensive Transfusion Reaction,Post-Transfusion Purpura,Posttransfusion Purpura,TAGHD,Transfusion-Associated Allergic Reaction,Transfusion-Associated Circulatory Overload,Transfusion-Associated Dyspnea,Transfusion-Associated Graft Vs. Host Disease,Transfusion-Transmitted Infection,Allergic Reaction, Transfusion-Associated,Blood Transfusion Associated Adverse Reactions,Circulatory Overload, Transfusion-Associated,Circulatory Overloads, Transfusion-Associated,Dyspnea, Transfusion-Associated,Febrile Non Hemolytic Transfusion Reaction,Hemolytic Transfusion Reactions,Infection, Transfusion-Transmitted,Post Transfusion Purpura,Posttransfusion Purpuras,Purpura, Post-Transfusion,Purpura, Posttransfusion,Reaction, Hemolytic Transfusion,Reaction, Hypotensive Transfusion,Reactions, Hemolytic Transfusion,Transfusion Associated Allergic Reaction,Transfusion Associated Circulatory Overload,Transfusion Associated Dyspnea,Transfusion Associated Graft Vs. Host Disease,Transfusion Reaction, Hemolytic,Transfusion Reaction, Hypotensive,Transfusion Reactions,Transfusion Reactions, Hemolytic,Transfusion Reactions, Hypotensive,Transfusion Transmitted Infection,Transfusion-Associated Circulatory Overloads,Transfusion-Transmitted Infections

Related Publications

Y Kosaka, and M Yamashiki
March 1993, American family physician,
Y Kosaka, and M Yamashiki
March 1993, American family physician,
Y Kosaka, and M Yamashiki
July 1987, Rinsho byori. The Japanese journal of clinical pathology,
Y Kosaka, and M Yamashiki
January 1984, Pediatric infectious disease,
Y Kosaka, and M Yamashiki
August 2013, Clinical liver disease,
Y Kosaka, and M Yamashiki
December 2015, Nihon rinsho. Japanese journal of clinical medicine,
Y Kosaka, and M Yamashiki
January 2005, International journal of medical sciences,
Y Kosaka, and M Yamashiki
June 2011, The Korean journal of hepatology,
Y Kosaka, and M Yamashiki
July 2016, Rinsho byori. The Japanese journal of clinical pathology,
Y Kosaka, and M Yamashiki
January 1987, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!